Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
68,000
-200 (-0.29%)
At close: Sep 4, 2026

KRX:185750 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,782,8301,692,4041,586,4311,669,4041,488,3451,343,559
Revenue Growth
7.15%6.68%-4.97%12.16%10.78%3.11%
Gross Profit
531,060526,378532,611662,202542,639495,818
Operating Income
77,17180,56899,462246,599109,90694,759
Net Income
79,47577,509109,073212,52180,95342,720
Earnings Per Share
5988.225845.548234.0015210.376013.653117.38
EPS Growth
29.54%-29.01%-45.87%152.93%92.91%-53.03%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
1,622,9951,512,2191,493,0731,423,2451,286,052
Others
19,23035,405133,98019,2087,340
Japan
43,13538,19741,15745,89143,913
Swiss
7,044610.64---
Total
1,692,4041,586,4311,669,4041,488,3451,343,559

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
329,300346,503302,171365,065155,861187,333
Total Debt
437,444367,758188,152219,764235,738237,054
Net Cash (Debt)
-108,144-21,255114,018145,301-79,877-49,721
Net Cash Growth
---21.53%---
Net Cash Per Share
-8116.54-1596.608607.8210399.38-5933.68-3628.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
123,25767,35964,289318,16067,73412,904
Capital Expenditures
-188,689-140,917-38,474-41,218-44,898-48,243
Free Cash Flow
-65,432-73,55825,815276,94222,836-35,339
Free Cash Flow Growth
---90.68%1112.74%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
29.79%31.10%33.57%39.67%36.46%36.90%
Operating Margin
4.33%4.76%6.27%14.77%7.38%7.05%
Pretax Margin
4.31%4.82%6.43%14.47%6.53%6.00%
Profit Margin
4.46%4.58%6.88%12.73%5.44%3.18%
FCF Margin
-3.67%-4.35%1.63%16.59%1.53%-2.63%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.3814.0910.817.8412.3830.72
Forward PE
13.2814.4714.4718.8414.2914.96
P/FCF Ratio
--45.676.0243.87-
PS Ratio
0.500.650.741.000.670.98